Related Experiment Video

Updated: Jul 16, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

[Medical oncology]

M S Aapro1

  • 1Clinique de Genolier, 1272 Genolier. maapro@genolier.net

Revue Medicale Suisse
|March 16, 2007
PubMed

Insights

The 2006 medical oncology landscape showed less promise than 2005, but new targeted cancer therapies like sunitinib and sorafenib offer hope for renal cell cancer patients.

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Research

Context:

  • The year 2006 presented challenges in medical oncology, with a general decrease in enthusiasm compared to 2005.
  • Advances in targeted therapies are emerging as a significant development in cancer treatment.

Purpose:

  • To review recent developments and identify areas for improvement in cancer treatment strategies.
  • To highlight specific agents showing promise in improving patient outcomes for renal cell carcinoma.

Summary:

  • Despite a general decline in enthusiasm in medical oncology in 2006, targeted therapies such as sunitinib and sorafenib have shown significant benefits for patients with renal cell cancer.
  • The reviewed literature emphasizes the critical need for more precise cancer treatment approaches, including chemotherapy, to enhance efficacy and minimize toxicity.

Impact:

  • The development and marketing of sunitinib and sorafenib represent a notable exception, offering improved outcomes for renal cell cancer patients.
  • Future advancements in targeted cancer therapy are anticipated to increase treatment effectiveness and reduce patient exposure to unnecessary toxicity.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.